Stay updated on Maintenance Olaparib & Cediranib vs Olaparib Alone Clinical Trial

Sign up to get notified when there's something new on the Maintenance Olaparib & Cediranib vs Olaparib Alone Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Maintenance Olaparib & Cediranib vs Olaparib Alone Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The ICON9 study record is now displayed with details about its comparison of maintenance olaparib plus cediranib versus olaparib alone for relapsed ovarian cancer, along with eligibility criteria, participating locations, and outcome measures.
    Difference
    100%
    Check dated 2026-11-12T10:43:01.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision marker changed from v3.7.2 to v3.8.0. The page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-29T09:52:05.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    An NIH announcement banner was added, directing visitors to updates and FAQs about the agency’s transition from “Artificial Intelligence” to “Super Intelligence” terminology.
    Difference
    1%
    Check dated 2026-10-22T08:43:26.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The page continues to display a 403 Forbidden error. The footer revision identifier changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-15T13:13:29.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov 403 Forbidden page displays revision v3.7.1 instead of v3.7.0.
    Difference
    0.2%
    Check dated 2026-10-08T14:46:51.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    No textual changes are reported for this page. The page currently displays a 403 Forbidden error indicating access restriction.
    Difference
    0.2%
    Check dated 2026-10-01T14:52:17.000Z thumbnail image

Stay in the know with updates to Maintenance Olaparib & Cediranib vs Olaparib Alone Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Maintenance Olaparib & Cediranib vs Olaparib Alone Clinical Trial page.